Equipment: Cytek Aurora EVO 5 Laser

The National Institutes of Health (NIH) is conducting a market survey to determine the availability and technical capability of qualified small businesses to provide a new Brand name or equal to Cytek Biosciences: Cytek Aurora EVO 5 Laser UV/YG/V/B/R and Cytek Aurora-CS 5 Laser UV/YG/V/B/R. The system must provide integrated, high-plex spectral particle/cytometric analysis and high-plex spectral cell/particle sorting with seamless workflow continuity, advanced unmixing capabilities, small particle detection, and compliance with current data standards. • The system must consist of both a spectral analyzer and a 6-way spectral cell sorter with small particle detection. • The system must operate with a 5-laser configuration and detect fluorescence up to 825 nm or higher wavelength. • The system must be compatible with major analysis platforms and include an automated QC module. • The analyzer must be equipped with an autoloader supporting various plate and tube formats. • The sorter must have a 6-way sorting capability and support aseptic sorting into various formats.